Bill > S2057

This bill, the Pharmaceutical Regulation Conflict of Interest Act, aims to prevent conflicts of interest that arise from the "revolving door" between pharmaceutical regulators and the private sector. The key provisions are: 1. Defining "covered pharmaceutical regulators" and "covered pharmaceutical regulatory agencies" to establish the scope of the regulations. 2. Prohibiting covered pharmaceutical regulators from working on matters that provide a direct financial benefit to their former employers or clients for two years after leaving government service. Regulators must recuse themselves from such matters, with limited waivers possible. 3. Requiring covered pharmaceutical regulators to disclose any negotiations for future private sector employment and restricting their ability to work for private clients or as lobbyists for two years after leaving government. 4. Establishing recordkeeping and enforcement mechanisms, including criminal and civil penalties for violations. 5. Expanding post-employment restrictions for pharmaceutical regulators under the existing conflict of interest laws. The overall goal is to slow the movement of pharmaceutical regulators into private sector roles that could influence their official duties and undermine the independence of the regulatory process.

Military Affairs and Security

https://www.congress.gov/bill/115th-congress/senate-bill/2057/all-info